載入...
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
The outbreak of a new coronavirus (SARS-CoV-2), which is responsible for the COVID-19 disease and is spreading rapidly around the world, urgently requires effective therapeutic treatments. In this context, drug repurposing represents a valuable strategy, as it enables accelerating the identification...
Na minha lista:
| 發表在: | Front Pharmacol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7938350/ https://ncbi.nlm.nih.gov/pubmed/33692695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.636989 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|